Published in Mol Cell Biol on January 01, 1997
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet (2001) 3.75
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res (2006) 3.29
Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet (2004) 2.40
BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci U S A (1997) 2.02
Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc Natl Acad Sci U S A (1999) 1.54
Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol Cell Biol (1999) 1.50
DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice. Nat Commun (2015) 1.49
Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci U S A (1997) 1.46
Emerging roles of BRCA1 alternative splicing. Mol Pathol (2003) 1.41
BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks. Mol Cell Biol (2003) 1.34
BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol (1999) 1.29
Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer. Cancer Discov (2012) 1.25
Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol (2003) 1.20
Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci. Mol Cell Biol (2001) 1.17
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. Mol Cancer (2009) 1.12
Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol (2003) 1.10
Transcriptional autoregulation by BRCA1. Cancer Res (2010) 1.05
PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair. Cancer Discov (2014) 1.02
KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ. Virchows Arch (2007) 0.98
A role for BRCA1 in sporadic breast cancer. Br J Cancer (2003) 0.98
BRCA1, BRCA2 and their possible function in DNA damage response. Br J Cancer (1999) 0.96
Functional domains of interferon regulatory factor I (IRF-1). Biochem J (1998) 0.96
BRCA1 and BRCA2 proteins: roles in health and disease. Mol Pathol (1998) 0.94
Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform. Mol Cell Biol (2006) 0.93
Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis. PLoS One (2012) 0.92
Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1. Exp Cell Res (2007) 0.92
Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines. Br J Cancer (2003) 0.92
The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study. J Clin Pathol (2001) 0.91
Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins. J Cell Physiol (2009) 0.90
KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer. Br J Cancer (2015) 0.89
Targeting nucleocytoplasmic transport in cancer therapy. Oncotarget (2014) 0.88
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) (2014) 0.88
Evolutionary constraint helps unmask a splicing regulatory region in BRCA1 exon 11. PLoS One (2012) 0.86
The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations. Scientifica (Cairo) (2012) 0.85
CCN5, a secreted protein, localizes to the nucleus. J Cell Commun Signal (2010) 0.85
Natural selection and mammalian BRCA1 sequences: elucidating functionally important sites relevant to breast cancer susceptibility in humans. Mamm Genome (2006) 0.85
A conditional mouse model for measuring the frequency of homologous recombination events in vivo in the absence of essential genes. Mol Cell Biol (2011) 0.83
Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. Int J Biol Sci (2007) 0.82
Impaired skin and mammary gland development and increased gamma-irradiation-induced tumorigenesis in mice carrying a mutation of S1152-ATM phosphorylation site in Brca1. Cancer Res (2009) 0.81
BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite. Breast Cancer Res (2000) 0.80
Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer. Onco Targets Ther (2017) 0.77
BRCA1 is a novel regulator of metabolic function in skeletal muscle. J Lipid Res (2014) 0.76
Protein mislocalization: mechanisms, functions and clinical applications in cancer. Biochim Biophys Acta (2014) 0.76
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem (1984) 66.58
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1993) 11.01
Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature (1984) 10.52
Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell (1995) 6.97
BRCA1 mutations in primary breast and ovarian carcinomas. Science (1994) 6.81
TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev (1990) 6.00
BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26
Aberrant subcellular localization of BRCA1 in breast cancer. Science (1995) 3.61
Growth retardation and tumour inhibition by BRCA1. Nat Genet (1996) 3.47
The RING finger. A novel protein sequence motif related to the zinc finger. Ann N Y Acad Sci (1993) 3.17
The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell (1989) 3.07
Nuclear localization signals (NLS). Crit Rev Eukaryot Gene Expr (1993) 3.05
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet (1994) 2.66
Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum Mutat (1996) 2.54
The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet (1995) 2.02
Location of BRCA1 in human breast and ovarian cancer cells. Science (1996) 1.88
Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Mol Cell Biol (1989) 1.87
Identification and characterization of two functional domains within the murine heavy-chain enhancer. Mol Cell Biol (1988) 1.81
Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res (1995) 1.43
Nuclear localization of the adenovirus DNA-binding protein: requirement for two signals and complementation during viral infection. Mol Cell Biol (1989) 1.23
Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. Hum Mol Genet (1995) 1.22
Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene (1996) 1.12
Murine Brca1: sequence and significance for human missense mutations. Hum Mol Genet (1995) 1.10
Response: Location of BRCA1 in Human Breast and Ovarian Cancer Cells. Science (1996) 0.90
A karyophilic signal sequence in adenovirus type 5 E1A is functional in Xenopus oocytes but not in somatic cells. J Virol (1989) 0.87
Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. Genomics (1995) 0.87
1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR (1995) 15.76
Experimental annotation of the human genome using microarray technology. Nature (2001) 10.39
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996) 7.09
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol (1999) 4.88
Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase. Nature (2001) 4.73
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med (1997) 4.33
Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissues. Stain Technol (1975) 4.04
Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA (1997) 3.94
Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell (1998) 3.86
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 3.81
SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet (1998) 3.79
Discovery of intense gamma-ray flashes of atmospheric origin. Science (1994) 3.47
Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res (2001) 3.45
RIM101-dependent and-independent pathways govern pH responses in Candida albicans. Mol Cell Biol (2000) 3.45
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37
Ethylene glycol poisoning: toxicokinetic and analytical factors affecting laboratory diagnosis. Clin Chem (1998) 3.32
Association of CYP2C9*2 with bosentan-induced liver injury. Clin Pharmacol Ther (2013) 3.29
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst (1999) 3.26
Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA (2000) 3.15
Centric heterochromatin and the efficiency of achiasmate disjunction in Drosophila female meiosis. Science (1996) 3.14
Model observers for assessment of image quality. Proc Natl Acad Sci U S A (1993) 3.08
The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med (1994) 3.05
Breast cancer genetics: what we know and what we need. Nat Med (2001) 2.96
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature (1997) 2.93
Superior mesenteric artery syndrome: diagnosis and treatment strategies. J Gastrointest Surg (2008) 2.89
17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Res (2000) 2.81
BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet (1996) 2.75
CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest (1998) 2.74
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet (1994) 2.66
Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther (2004) 2.55
Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum Mutat (1996) 2.54
Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA (1993) 2.51
Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA (1995) 2.50
Recent advances in breast cancer biology. Curr Opin Oncol (1999) 2.46
BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene (1998) 2.39
Low back pain. J R Coll Gen Pract (1968) 2.39
Structural and dynamic characterization of partially folded states of apomyoglobin and implications for protein folding. Nat Struct Biol (1998) 2.36
Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res (1993) 2.35
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst (1998) 2.33
Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet (1997) 2.31
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2010) 2.27
Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology (2006) 2.17
The evolution of polyploid wheats: identification of the A genome donor species. Genome (1993) 2.15
Ocean surface currents mapped by radar. Science (1977) 2.15
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet (1999) 2.14
Red cell distribution width as predictor for mortality in critically ill patients. Neth J Med (2013) 2.13
Variation in repeated nucleotide sequences sheds light on the phylogeny of the wheat B and G genomes. Proc Natl Acad Sci U S A (1990) 2.12
The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet (1995) 2.02
Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Mol Cell (1998) 2.00
Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology (2011) 1.99
The RAD50 gene, a member of the double strand break repair epistasis group, is not required for spontaneous mitotic recombination in yeast. Curr Genet (1990) 1.93
Delayed rectifier K currents have reduced amplitudes and altered kinetics in myocytes from infarcted canine ventricle. Cardiovasc Res (2000) 1.90
Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res (1995) 1.85
p53 point mutation and survival in colorectal cancer patients. Cancer Res (1995) 1.85
Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol (2001) 1.85
Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase. Mol Cell Biol (2000) 1.83
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res (2001) 1.81
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet (1996) 1.79
Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res (2001) 1.77
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet (1995) 1.75
"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum Gene Ther (1996) 1.70
Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin Chem (1997) 1.67
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst (2000) 1.64
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol (2006) 1.63
Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol (2000) 1.54
HSP101 functions as a specific translational regulatory protein whose activity is regulated by nutrient status. Genes Dev (1998) 1.52
Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy. Am J Med Genet (1999) 1.52
BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol (1998) 1.52
Bacterial artificial chromosome-based physical map of the rice genome constructed by restriction fingerprint analysis. Genetics (2001) 1.49
The DCL gene of tomato is required for chloroplast development and palisade cell morphogenesis in leaves. EMBO J (1996) 1.49
The role of cholangiography in laparoscopic cholecystectomy. Arch Surg (1991) 1.48
Ultrasonography and indium 111 white blood cell scanning for the detection of intraabdominal abscesses. Radiology (1981) 1.48
Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet (1993) 1.45
Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice. Hum Mol Genet (2000) 1.44
Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. Hum Mol Genet (2000) 1.44
Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes. Invest Ophthalmol Vis Sci (1991) 1.44
Homocysteine theory of arteriosclerosis. Atherosclerosis (1976) 1.43
Increased transcriptional activity of the CYP3A4*1B promoter variant. Environ Mol Mutagen (2003) 1.42
Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol (1996) 1.42
Agreement among three quality of life measures in patients with ALS. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 1.42
The structure of normal human attention: The Test of Everyday Attention. J Int Neuropsychol Soc (1996) 1.42
Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics (1996) 1.41
Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis (1999) 1.41
Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene (2008) 1.40
Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res (1997) 1.39
Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. J Virol (1997) 1.38
IN VIVO AND IN VITRO OBSERVATIONS OF LEPTOSPIRA POMONA BY ELECTRON MICROSCOPY. J Bacteriol (1962) 1.38
UV-induced hyperphosphorylation of replication protein a depends on DNA replication and expression of ATM protein. Mol Biol Cell (2001) 1.38